Although VEGF might be a potential biomarker or risk factor, as shown in observational studies, our study failed to obtain convincing evidence that VEGF increases the risk of malignant brain tumors, brain glioblastoma and malignant neoplasm of meninges using the strong IVs from GWAS summary data, and vice versa. This evidence concerns the gene VEGFA and brain cancer.